Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key

Stroke

Volumn 34, Issue 5, 2003, Pages 1334-1335

  Bath, Philip ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Angiotensin converting enzyme inhibitors; Blood pressure; Randomized controlled trials; Stroke prevention

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; PERINDOPRIL; RAMIPRIL;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL; SECONDARY PREVENTION; SHORT SURVEY; STROKE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; DIURETICS; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; INDAPAMIDE; ISCHEMIC ATTACK, TRANSIENT; META-ANALYSIS; MYOCARDIAL INFARCTION; PERINDOPRIL; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TREATMENT OUTCOME;

EID: 0038304314     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000069267.19971.7D     Document Type: Short Survey

References (10)

1. Rashid PA, Leonardi-Bee J, Bath PM. Lowering blood pressure after stroke or transient ischaemic attack to prevent recurrence: a systematic review of randomised controlled trials. Cerebrovasc Dis. 2002;13(suppl 3):92. Abstract.
2. The Dutch TIA Study Group. Trial of secondary prevention with atenolol after transient ischaemic attack or nondisabling ischaemic stroke. Stroke. 1993;24:543-548.
3. Eriksson S, Olofsson B-O, Wester P-O. Atenolol in secondary prevention after stroke. Cerebrovasc Dis. 1995;5:21-25.
4. Carter AB. Hypotensive therapy in stroke survivors. Lancet. 1970;1: 485-489.
5. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA. 1974;228:409-418.
6. PATS Collaborating Group. Post-stroke antihypertensive treatment study: a preliminary result. Chin Med J. 1995;108:710-717.
7. The Heart Outcome Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N EngI J Med. 2000;342: 145-153.
8. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension. 2001;38:e28-e32.
9. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358:1033-1041.
10. Staessen JA, Wang J-G, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305-1315.